Seth Loring Harrison
CIK: 0001404955
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
17.8K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
19.4K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
7.6K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
7.6K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
29.7K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
29.7K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
17.8K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
29.6K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
29.6K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
14.8K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
14.8K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
11.7K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
11.7K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
21K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)IndirectStock Option (Right to Buy)
21K shares- - Jul 16, 2026STOK
Stoke Therapeutics, Inc.
Gift(G)DirectStock Option (Right to Buy)
19.4K shares- - Jun 3, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
17.8K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
Disposition(D)Indirect148.1K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
Disposition(D)Direct9.4K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
Disposition(D)Direct136.3K shares- - Jun 3, 2025AKRO
Akero Therapeutics, Inc.
Award(A)Direct9.4K shares- - Jun 3, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
29.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 17,786 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 19,441 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 7,639 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 7,639 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 29,747 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 29,747 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 17,786 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 29,555 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 29,555 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 14,777 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 14,777 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 11,650 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 11,650 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 21,000 | - | - | Direct |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 21,000 | - | - | Indirect |
| Jul 16, 2026 | STOK Stoke Therapeutics, Inc. | Gift(G) Stock Option (Right to Buy) | 19,441 | - | - | Direct |
| Jun 3, 2026 | STOK Stoke Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 17,786 | - | - | Direct |
| Dec 9, 2025 |  AKRO Akero Therapeutics, Inc. | Disposition(D) | 148,063 | - | - | Indirect |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition(D) | 9,398 | - | - | Direct |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition(D) | 136,301 | - | - | Direct |
| Jun 3, 2025 | AKRO Akero Therapeutics, Inc. | Award(A) | 9,398 | - | - | Direct |
| Jun 3, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Director Stock Option (Right to Buy) | 29,747 | - | - | Direct |
1-22 of 22 transactions
About Harrison Seth Loring
Harrison Seth Loring (SEC CIK 0001404955) files insider reports with the SEC as Director of Stoke Therapeutics, Inc. (STOK) and Director of Akero Therapeutics, Inc. (AKRO).
Signal8 holds 5 ownership filings by Harrison Seth Loring, all Form 4s, filed between Jun 4, 2025 and Jul 17, 2026. Those filings report 22 transactions, from Jun 3, 2025 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Harrison Seth Loring's filings is in BEDFORD, MA.
Recent filings by Harrison Seth Loring
- Jul 16, 2026: Gifts of STOK derivative securities (16 lines, Form 4, code G).
- Jun 3, 2026: Grant or award of STOK derivative securities (Form 4, code A).
- Dec 9, 2025: Disposition to issuer transactions of AKRO shares (3 lines, Form 4, code D).
- Jun 3, 2025: Grant or award of AKRO shares (Form 4, code A).
- Jun 3, 2025: Grant or award of STOK derivative securities (Form 4, code A).
Other insiders filing for Stoke Therapeutics, Inc. (STOK)
- Allan Jonathan, GENERAL COUNSEL & CORP SEC
- Ticho Barry, CHIEF MEDICAL OFFICER
- Cumbo Alexander, Director
- Kaye Edward M. MD, Director
- McCauley Thomas, Chief Scientific Officer
- TZIANABOS ARTHUR, Director